Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1996 Jun;164(6):489-95.
doi: 10.1055/s-2007-1015694.

[Therapeutic efficiency of of pulsed spray lysis in peripheral arterial occlusions]

[Article in German]
Affiliations
Clinical Trial

[Therapeutic efficiency of of pulsed spray lysis in peripheral arterial occlusions]

[Article in German]
T Roeren et al. Rofo. 1996 Jun.

Abstract

Purpose: To determine the clinical efficacy of pulse-spray thrombolysis.

Material and methods: In a prospective trial 28 patients with acute arterial (n = 14) and bypass (n = 14) occlusions of the lower extremities were treated with pulse spray thrombolysis. 23/28 legs were at risk.

Results: Technical and clinical success were 89% and 68% respectively. Time interval until restitution of antegrade flow was less than two hours, the median duration of the complete intervention was 17 hours. Two patients (7.1%) needed transfusions for inguinal haematomas. After six months 50% of occluded segments remained patent, secondary patency is comparable at 53%. Bypasses show significantly lower patency (p = 0.04) and higher amputation (p = 0.009) rates than native arteries. Bad run-off (< or = 1 artery patent) is a significant predictor for clinical failure and early amputation.

Conclusions: The distinct advantage of pulse-spray thrombolysis is fast restoration of antegrade flow and thereby effective treatment of acute ischaemia. The complication rate is low without associated mortality.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources